Pharmacopoeia and Homoeopathic Pharmacy in details by Dr Poonam Singh and Dr Pranesh Singh Sri Ganganagar Homoeopathic Medical college Sri Ganganagar rajasthan
This scale was introduced by Hahnemann in 5th edition of Organon of Medicine, aphorism 270 and is more commonly used.
Two methods of preparing medicines are recognized, one on the decimal, the other on the centesimal scale. The pure tinctures are denominated "mother tinctures,"
Pharmacopoeia and Homoeopathic Pharmacy in details by Dr Poonam Singh and Dr Pranesh Singh Sri Ganganagar Homoeopathic Medical college Sri Ganganagar rajasthan
This scale was introduced by Hahnemann in 5th edition of Organon of Medicine, aphorism 270 and is more commonly used.
Two methods of preparing medicines are recognized, one on the decimal, the other on the centesimal scale. The pure tinctures are denominated "mother tinctures,"
Homoeopathic dynamisation in detail with recent techniques of potentisation is explained. Trituration and succusion is also discussed. All the terms available according to different author are published.
Sources & evolution of homoeopathic materia medicasarojsawant2
Homoeopathic Materia Medica :
The Record book of the effects of drugs on human beings
Earlier materia medicas have details regarding the materials and methods which may be used to prepare homeopathic medicines. There are different sources of materia medica such as plants, animal proving, clinical proving, toxicological findings, emperical methodas etc.
Concept of homoeopathic materia medicasarojsawant2
Materia Medica is a Latin medical term
for the body of collected knowledge
about the therapeutic properties of
any substance(drug) used for healing with their sources, preparations, doses and use.
Homoeopathic dynamisation in detail with recent techniques of potentisation is explained. Trituration and succusion is also discussed. All the terms available according to different author are published.
Sources & evolution of homoeopathic materia medicasarojsawant2
Homoeopathic Materia Medica :
The Record book of the effects of drugs on human beings
Earlier materia medicas have details regarding the materials and methods which may be used to prepare homeopathic medicines. There are different sources of materia medica such as plants, animal proving, clinical proving, toxicological findings, emperical methodas etc.
Concept of homoeopathic materia medicasarojsawant2
Materia Medica is a Latin medical term
for the body of collected knowledge
about the therapeutic properties of
any substance(drug) used for healing with their sources, preparations, doses and use.
Official Book Used in Pharmacy| Literature of Pharmacy| L 05|Un-Official| Pha...Tayyeb Mehmood
key point are:
Pharmacopoeias & formulary
Classification of compendia
Monograph with example
British Pharmacopoeia (BP)
British Pharmaceutical Codex (BPC)
International & National Pharmacopoeia
United States Pharmacopoeia (USP) -National Formulary (NF)
The state Pharmacopoeia of USSR
Pakistan Pharmacopeia
Indian Pharmacopeia
Merck Index, Martindale & Others
Pharmacopoeia: the word derives from the ancient Greek word pharmakon means drug & poeia- to make.
It is a legally binding collection, prepared by a national or regional authority& contains list of medicinal substances, crude drug & formulas for making preparation from them.
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
Pharmacopoeia is the official book of standards for drugs prepared by any country or regulatory body to specify the standards of identity, purity and strength for the drugs imported, manufactured or distributed throughout the country or a specific region.
Comparison of various herbal pharmacopoeias.pptxEasy Concept
Herbal Pharmacopoeia is a reference book for the preparation of quality medicines published by the authority of a Government and represents qualitative and therapeutic monographs on botanicals
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
3. Homoeopathic Pharmacopoeia
A supreme authoritative book, published by an
authority, govt of any country that contains a list of
drugs used in homoeopathy approved by authority, and
deals with the rules & regulations of standardization of
drug substances.
www.experthomeo.com
7. Origin & Evolution of Hom. Pharmacopoeia
1805 – Samuel Hahnemann announced his new
method of pharmacological process in a treatise:
Fragmenta de Viribus Medicamentorum Positivis Sive in
Sano Corpore (Fragmentary observations relative to the
Positive Powers of Medicines on the Human Body)
1825 – Carl W Casperi of Leipzig, Germany gathered
material from Organon of Medicine, The Chronic
Disease, & Materia Medica Pura and published First
Hom. Pharmacopoeia: Dispensatorium Homeopathicum
It was translated into Latin by Dr. Hartmann and this
Latin translation was reprinted in England In 1829
www.experthomeo.com
8. Origin & Evolution of Hom. Pharmacopoeia
1842 – Jahr brought out New Homeopathic
Pharmacopoeia and Posology for preparation of hom.
medicines & administration of doses
1845 – Mr. Gruner of Dresden introduced some
technical improvements in his pharmacopoeia. He
recommended precipitating metal for their trituration
1845 – G Schmidt recommended water in stead of
alcohol for preparing 1st
attenuation from acids in his
pharmacopoeia. He advised to prepare attenuation of
phosphorus directly from tincture. He recommended
different strength of alcohol for preparing different
vegetable tincture.
www.experthomeo.com
9. Origin & Evolution of Hom. Pharmacopoeia
1852 – Dr. Buchner published a pharmacopoeia
describing the mode of preparing hom. medicines
1870 – British Homoeopathic Society published
British Homoeopathic Pharmacopoeia which was
accepted by whole hom. world as a standard one
1892 – M Bhattacharyya & Co. published first hom.
pharmacopoeia in India
www.experthomeo.com
10. Origin & Evolution of Hom. Pharmacopoeia
1897 – American Homoeopathic society published
American Homoeopathic Pharmacopoeia
1901 - Homoeopathic Pharmacopoeia of United States
appeared with the concept of uniform drug strength of
10%
1971 – Govt. of India, Ministry of Health &
Family Welfare published first volume of
Homoeopathic Pharmacopoeia of India (HPI) to
lay down the standard for preparation of hom. medicines
in the country. So far nine volumes of HPI are published
www.experthomeo.com
11. Functions
• To enlist drugs with their description, both macroscopic
& microscopic
• To set guidelines for collecting & preserving raw
materials
• To lay down principles & standards for preparation of
drugs
• To lay down tests for identity, quality, & purity for raw
materials as well as finished products
• To give idea on doses of individual drugs
• To serve as a guidelines to pharmacists & physicians
www.experthomeo.com
12. German Homoeopathic Pharmacopoeia
(GHP)
Homoeopathisches Dispensatorium fur Aerzte and
Apothekar
by
Carl W Casperi – 1825: Leipzig, Germany
• Produced idea of hom. pharmacopoeia and viewed the
concept that hom. system of medicine should have its
own pharmacopoeia
• Mostly reproduced Hah. Method of prepn
of drugs
www.experthomeo.com
13. Pharmacopoeia Homoeopathic Polyglotta
by
Von Willmar Schwabe – 1872
1880; 2nd
edn (in English)
1929; 2nd
English edn:-
sponsored by German Federal Govt. which was later
revised & known today as Dr. Willmar Schwabe
Homoeopathisches Arzneibuch (HAB) which was
subsequently accepted as Official GHP
www.experthomeo.com
Founded Hom. Central Pharmacy to
manufacture & sell Hom. Medicines in
1866. Created precise standards for
Hom. prepn
15. Permitted Vehicles
www.experthomeo.com
• Purified water
• Absolute ethanol
• Ethanol of various
strength: 86%, 73%,
62%, 43%, 30%, &
15%
• Glycerol 85%
• Water for injections
• Lactose
• Sucrose
• Vegetable oils:
Groundnut oil, Olive oil,
Sesame oil
• Wood charcoal etc.
16. British Homoeopathic Pharmacopoeia
(BHP)
British Homoeopathic Pharmacopoeia
by
British Homoeopathic society – 1870: London,
England
by; E Gould & Son – 1876: 2nd
edn
1882: 3rd
edn
by; British Homoeopathic – 1993: 4th
edn
Manufacturers’ Association
(BAHM)
www.experthomeo.com
unofficial
17. Special Features
• Consideration of effect of plant moisture
• Use of different strength of alcohol for drug prepn
• Accurate description of drugs in detail
www.experthomeo.com
18. Contents (4th edn)
Part 1:
• Background information to the manufacturers
• Abbreviations
• Analytical methods
• Reagents
• General regulations for the manufacture of hom.
medicines
• Index to all manufacturing methods with ref. to the
source of methods
Part 2: Monographs
www.experthomeo.com
19. Homoeopathic Pharmacopoeia of France
Pharmacopee Homoeopathique Francaise
Published in 1898; Ran into several editions
Special Features
Added new drugs in categories of nosodes, organs,
tissues, biochemicals/organochemicals, and minerals
www.experthomeo.com
20. Category of Products
• Mother Tinctures
• Potencies in decimal D, DH, X or XH, & centesimal C or
CH
• Combinations of above
www.experthomeo.com
23. American Hom. Pharmacopoeia (AHP)
American Homoeopathic Pharmacopoeia
by
Boericke & Tafel – 1882: New York & Philadelphia
1904:10th
edn
Companion To The British & American
Homoeopathic Pharmacopoeias
Compiled by – Lawrence T. Ashwell
Published by – Keen & Ashwell
1882: 1st
edn; 1883: 2nd
edn; 1884:3rd
edn; 1890:4th
edn
www.experthomeo.com
Unofficial
24. Pharmacopoeia of the American Institute of
Homeopathy
by
Otis Clap & Son Inc. Agent – 1897: Boston,
USA
Hom. Pharmacopoeia 1901: 2nd
edn
of United States (HPUS)
1938 – Had sole Authority for preparing hom.
medicines in USA (by effect of Food, Drug &
Cosmetic Act / Pure Food Law)
www.experthomeo.com
unofficial
25. 1940-41 – P/C Committee appointed by USA Govt.
Recommended uniform Drug Strength of
10% for all drugs except few
HPUS 1941: 6th
edn
1964: 7th
edn (Revised)
1979: 8th
edn; vol I
1979: 8th
edn; Compendium of
Homoeo – therapeutics
1982: 8th
edn; Supplement A
Hom. Pharmacopoeia of United States / Revision
Service (HPRS)
www.experthomeo.com
Official
26. Category of Products
• Liquid Attenuation of Soluble Substances
• Hom. Tinctures of Botanical Substances 1/10 (10%)
• Hom. Tinctures of Botanical Substances 1/20 (20%)
• Hom. Tinctures of Zoological Substances 1/20 (20%)
• Triturations
• Hom. Attenuations of Nosodes
• Hom. Attenuations of Allersodes (from antigens)
• Hom. Attenuations of Isodes (from excipients, binders, or
drugs)
• Hom. Attenuations of Sarcodes
www.experthomeo.com
29. Indian Hom. Pharmacopoeia (IHP)
Pharmaceutist Manual
by
M Bhattacharyya & Co. – 1892: Calcutta
1944:10th
edn; 70 Indian
drugs added
M Bhattacharyya & Co’s 1962:12th
edn; Revised &
Hom. Pharmacopoeia
enlarged
1980: 14th
edn
www.experthomeo.com
Unofficial
30. Homoeopathic Pharmacopoeia of India (HPI)
Historical Background
1956: Hom. Advisory Committee proposed to set up
Hom. Pharmacopoeia Committee
1961Sep: Hom. Subcommittee of the Drugs Technical
Advisory Board strongly endorsed the Proposal
1962 May: Ministry of Health, Govt. of India appointed Dr.Dr.
K G SaxenaK G Saxena as Honorary Hom. Adviser to
Govt.
www.experthomeo.com
Unofficial
31. Historical Background
1962 Sep: Hom. Pharmacopoeia Committee constituted
ChairmanChairman – Dr. B K Sarkar
TermTerm – 3 yrs, extended subsequently
ObjectivesObjectives – 1. To prepare A PharmacopoeiaPharmacopoeia of Hom.
Drugs (ref. AHP, GHP, & BHP)
2. To lay down Principles & StandardsPrinciples & Standards for
the preparation of Hom. Drugs
3. To lay down TestsTests of identity, quality,
purity
4. Such other matters as are incidental and
necessary for the PreparationPreparation of Hom.
Pharmacopoeia
www.experthomeo.com
32. Historical Background
ActivitiesActivities – 1962 Nov1962 Nov: in the 1st
meeting preliminary
matters regarding preparation of HPI
discussed // a questionnaire circulated to
leading Hom. Pharmacist & Homoeopaths // a
Sub-committee formed to draw up a list of
drugs for pharmacopoeia
1967 Mar1967 Mar: list of 2000 Hom. Drugs finalized
//pharmacopoeia to be brought out in stages //
180 common drugs including some
indigenous drugs in Vol I // drafts of
monograph prepared, circulated to committee
members & manufacturers
www.experthomeo.com
33. Contents (Vo I)
• Preface
• Introduction
• Historical
• General Notices
• Abbreviation
• Monographs
• Appendices (I to XIX)
www.experthomeo.com
34. www.experthomeo.com
VolumeVolume No. of MonographNo. of Monograph Year of PublicationYear of Publication
II
IIII
IIIIII
IVIV
VV
VIVI
VIIVII
VIIIVIII
IXIX
180180
100100
105105
107107
114114
104104
105105
101101
100100
19711971
19741974
19781978
19831983
19861986
19901990
19991999
20002000
20062006
35. Monograph
A detailed record of the standard specifications of each drug
medicine recorded in the Pharmacopoeia
www.experthomeo.com
For Plants:
• Name with abbreviation
• Botanical name
• Family
• Common name
• Description
• Part used
• Macroscopical
For Animals:
• Zoological name in place of
Botanical name
• Microscopical
• Identification tests
• Distribution
• History & authority
• Preparation
• Storage
• Caution
• Macroscopical & Identifn
tests
omitted
36. Monograph
www.experthomeo.com
For Chemicals
• Name with abbreviation
• Symbol/Chemical
formula
• Molecular weight
• English name
• Description
• Identification
• Reaction
• Limit tests
• Assay
• History & authority
• Preparation
• Storage
• Caution
37. Monograph
www.experthomeo.com
For Nosodes
• Name with abbreviation
• Microbiological name
• History & authority
• Source of prepn
of
homoeo. drugs
• Description/morphology
of the organism
• Cultural characteristics
• Resistance & metabolism
• Biochemical reaction
• Preparation
• Storage
• Caution
38. Dr.A.B.Ram Jyothis MD (Hom)
Reader
Department of Homoeopathic Pharmacy
Athurasramam NSS Homoeopathic Medical College
Phone No: 9497053705
www.experthomeo.com
